Ob
ObsEva (XOMA)
Geneva CHFounded 201230 employees
Private CapbiotechAcquiredWomen's Health
Platform: Linzagolix Gyn
Market Cap
N/A
All Drugs
4
Clinical Trials
10
Failed / Terminated
1
FDA Approved
2
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sovazumab | OBS-5255 | NDA/BLA | 1 | IL-17A | SLEBCC | ||
| OBS-1037 | OBS-1037 | Preclinical | 1 | MDM2 | MDSFSGS | ||
| Tixatenlimab | OBS-6322 | Approved | 4 | GIP-R | SCDUC | ||
| Lirarelsin | OBS-2472 | Approved | 4 | GIP-R | Pancreatic CaMDS |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (9)